SCHEMBL18409256

SCHEMBL18409256

COc1ccc(CN(C(C)=O)c2nc(Cl)cc3c2ncn3C)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSPO P30536 4/20 0.46
SMN1; SMN2 Q16637 5/20 0.42
ALDH1A1 P00352 3/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
CCNE2 O96020 2/20 0.41
CCNE1 P24864 2/20 0.41
CDK2 P24941 2/20 0.41
BCL2A1 Q16548 4/20 0.39
HTT P42858 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HSP90AA1 P07900 1/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
CCR2 P41597 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409171 0.88 SMN1; SMN2 (0.43) TSPOSMN1; SMN2ALDH1A1CCNE2CCNE1
SCHEMBL2771027 0.87 CCNE2 (0.38) TSPOSMN1; SMN2ALDH1A1CCNE2CCNE1
SCHEMBL18409115 0.86 POLB (0.40) TSPOSMN1; SMN2ALDH1A1TSHRHTT
SCHEMBL18409118 0.85 CCNE2 (0.36) TSPOSMN1; SMN2ALDH1A1CCNE2CCNE1
SCHEMBL18409177 0.81 CCNE2 (0.36) TSPOSMN1; SMN2ALDH1A1CCNE2CCNE1
SCHEMBL3039547 0.77 MCL1 (0.36) TSPOSMN1; SMN2ALDH1A1CCNE2CCNE1
SCHEMBL18409257 0.76 JAK2 (0.36) TSPOSMN1; SMN2ALDH1A1TSHRMAPK1
SCHEMBL18409146 0.75 CCNE2 (0.42) SMN1; SMN2ALDH1A1TSHRCCNE2CCNE1
SCHEMBL1512298 0.75 POLB (0.37) SMN1; SMN2ALDH1A1TSHRHTTMEN1
SCHEMBL2767424 0.73 CCNE1 (0.67) SMN1; SMN2ALDH1A1CCNE2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 WO disclosed